Key result
Beating heart mitral valve surgery in high-risk patients resulted in a 30-day mortality rate of 7.5% for those without cardiogenic shock and 28.6% for those with shock (P=0.338).
Cohort (n=120)
No
Beating heart mitral valve surgery is a feasible option with favorable postoperative outcomes for high-risk patients considered unsuitable for conventional mitral valve surgery.
OBJECTIVES: The purpose of the study was to test whether a beating heart mitral valve operation was a valuable option in a heterogeneous group of patients considered very high risk for conventional mitral valve surgery. METHODS: We conducted a retrospective, single-centre, observational cohort study of 120 patients (mean age 63.7 ± 12.1 years, range 25.3-88.8 years; mean logistic EuroSCORE 26.1 ± 20.6%, range 1.5-84.3%) undergoing beating heart mitral valve operations using normothermic cardiopulmonary bypass without aortic cross-clamping and without cardioplegia between September 2002 and April 2014. Preoperatively, 14 (11.7%) patients were in cardiogenic shock, 16 (13%) on a ventilator, 33 (27.5%) receiving inotropic support, 12 (10%) on dialysis and 1 on extracorporeal membrane oxygenation. Sixty-five (54%) patients had had at least 1 (range 1-6) previous heart operation. The mean follow-up period was 920 ± 973 days. RESULTS: A mitral valve procedure was performed alone in 75 (62.5%) patients and combined with additional cardiac procedures in 45 (37.5%). Fifty-eight (49%) patients had emergency or urgent procedures and 62 (51%), elective procedures. The mean cardiopulmonary bypass time was 103 ± 39 min (median 94 min, range 45-252, interquartile range 75-121.5 min). There were no conversions to conventional procedures and no intraoperative deaths. The 30-day mortality rate for patients without cardiogenic shock was 7.5% (8 deaths among 106 patients). Among 14 (11.7%) patients who underwent an operation in cardiogenic shock, 4 died during the first 30 days (30-day mortality rate = 28.6%, Fisher's exact test P = 0.338 versus patients without shock). The lowest 30-day mortality rate was in patients operated on with the beating heart because of a porcelain aorta (n = 8 patients, 30-day mortality rate = 0%). CONCLUSIONS: Patients considered unsuitable for a conventional mitral valve operation had favourable postoperative outcomes if the operation was performed on the beating heart.
No takes yet. Share an insight, caveat, or question.
Pašić et al. (2017) conducted a cohort in Very high risk for conventional mitral valve surgery (n=120). Beating heart mitral valve surgery was evaluated on 30-day mortality (cardiogenic shock vs no shock) (p=0.338). Beating heart mitral valve surgery in high-risk patients resulted in a 30-day mortality rate of 7.5% for those without cardiogenic shock and 28.6% for those with shock (P=0.338).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: